TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Galecto Announces Acquisition of Damora Therapeutics

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Galecto, Inc.
Galecto Announces Acquisition of Damora Therapeutics

Galecto acquired Damora Therapeutics, a biotechnology company developing therapies for myeloproliferative neoplasms, in a transaction accompanied by a $285 million private investment that positions the company to advance potentially breakthrough treatments for blood cancers.

Insights
BACpK   neutral

Buffett is gradually selling Bank of America stock due to increased valuation and changing interest rate environment, suggesting a pragmatic investment approach


GLTO   positive

Completed strategic acquisition, raised significant capital, expanded pipeline with promising therapeutic assets